Barbara Montico

Aviano, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Correction: Suppression of Spry1 reduces HIF1α‑dependent glycolysis and impairs angiogenesis in BRAF‑mutant cutaneous melanoma.

Correction: Suppression of Spry1 reduces HIF1α‑dependent glycolysis and impairs angiogenesis in BRAF‑mutant cutaneous melanoma.

Journal: Journal of experimental & clinical cancer research : CR
Published: August 21, 2026

Non-coding RNA profiling in BRAFV600E-mutant cutaneous melanoma before and after Spry1 depletion.

Non-coding RNA profiling in BRAFV600E-mutant cutaneous melanoma before and after Spry1 depletion.

Journal: Scientific data
Published: June 13, 2025

Unraveling the role of hypoxia-inducible factors in cutaneous melanoma: from mechanisms to therapeutic opportunities.

Unraveling the role of hypoxia-inducible factors in cutaneous melanoma: from mechanisms to therapeutic opportunities.

Journal: Cell communication and signaling : CCS
Published: February 14, 2025

Suppression of Spry1 reduces HIF1α-dependent glycolysis and impairs angiogenesis in BRAF-mutant cutaneous melanoma.

Suppression of Spry1 reduces HIF1α-dependent glycolysis and impairs angiogenesis in BRAF-mutant cutaneous melanoma.

Journal: Journal of experimental & clinical cancer research : CR
Published: September 02, 2024

Antibody dependent cellular cytotoxicity-inducing anti-EGFR antibodies as effective therapeutic option for cutaneous melanoma resistant to BRAF inhibitors.

Antibody dependent cellular cytotoxicity-inducing anti-EGFR antibodies as effective therapeutic option for cutaneous melanoma resistant to BRAF inhibitors.

Journal: Frontiers in immunology
Published: November 10, 2023

Phospholipid scramblase 1 is involved in immunogenic cell death and contributes to dendritic cell-based vaccine efficiency to elicit antitumor immune response in vitro.

Phospholipid scramblase 1 is involved in immunogenic cell death and contributes to dendritic cell-based vaccine efficiency to elicit antitumor immune response in vitro.

Journal: Cytotherapy
Published: June 22, 2023

Autophagy in BRAF-mutant cutaneous melanoma: recent advances and therapeutic perspective.

Autophagy in BRAF-mutant cutaneous melanoma: recent advances and therapeutic perspective.

Journal: Cell death discovery
Published: February 09, 2023

LINE-1 hypomethylation is associated with poor outcomes in locoregionally advanced oropharyngeal cancer.

LINE-1 hypomethylation is associated with poor outcomes in locoregionally advanced oropharyngeal cancer.

Journal: Clinical epigenetics
Published: August 02, 2022

Integration of miRNA:mRNA Co-Expression Revealed Crucial Mechanisms Modulated in Immunogenic Cancer Cell Death.

Integration of miRNA:mRNA Co-Expression Revealed Crucial Mechanisms Modulated in Immunogenic Cancer Cell Death.

Journal: Biomedicines
Published: May 31, 2022

Phospholipid scramblase 1: a protein with multiple functions via multiple molecular interactors.

Phospholipid scramblase 1: a protein with multiple functions via multiple molecular interactors.

Journal: Cell communication and signaling : CCS
Published: March 08, 2022

Long Noncoding RNAs as Innovative Urinary Diagnostic Biomarkers.

Long Noncoding RNAs as Innovative Urinary Diagnostic Biomarkers.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: March 02, 2021

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1.

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1.

Journal: Autophagy
Published: February 26, 2021
Showing 1-12 of 21

Last Updated: 09/26/2026